rilonacept 220 MG Injection [Arcalyst]
- RxCUI
- 763457
- RxNorm name
- rilonacept 220 MG Injection [Arcalyst]
- Display name
- rilonacept 220 MG Injection [Arcalyst]
- Full name
- rilonacept 220 MG Injection [Arcalyst]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125249 | Arcalyst | rilonacept | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arcalyst | RILONACEPT | Kiniksa Pharmaceuticals (UK), Ltd. | ad965f38-dd22-4607-a673-2fb92f3b527a | 2025-12-16 | Warnings, Adverse reactions | 763457 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ad965f38-dd22-4607-a673-2fb92f3b527a | rilonacept 220 MG Injection [Arcalyst] | SBD | 16 | These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST ® (rilonacept) for injection, for subcutaneous use Initial U.S. Approval: 2008 | 20251216 |
| ad965f38-dd22-4607-a673-2fb92f3b527a | Arcalyst 220 MG Injection | SY | 16 | These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST ® (rilonacept) for injection, for subcutaneous use Initial U.S. Approval: 2008 | 20251216 |
| ad965f38-dd22-4607-a673-2fb92f3b527a | Arcalyst 220 MG Injection | PSN | 16 | These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST ® (rilonacept) for injection, for subcutaneous use Initial U.S. Approval: 2008 | 20251216 |